11/23/22 8:45 AMNasdaq : CMND clinical triallow floatClearmind Announces Initiation of CMND-100 Manufacturing Program to Address its Upcoming Clinical TrialClearmind Medicine Inc. (Nasdaq: CMND), (CSE: CMND), (FSE: CWY) (“ Clearmind ” or the " Company"), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, todayRHEA-AIneutral
11/17/22 12:15 PMNasdaq : CMND offeringlow floatAegis Capital Corp. Acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind Medicine Inc. (NASDAQ: CMND)Aegis Capital Corp. acted as Sole Bookrunner on a $7.5 Million Underwritten Public Offering & Uplisting for Clearmind Medicine Inc.RHEA-AIneutral
11/17/22 11:43 AMNasdaq : CMND offeringlow floatClearmind Medicine Announces Closing of US$7.5 Million Public Offering and Uplisting to the Nasdaq Capital Market Clearmind Medicine Inc. (Nasdaq and CSE: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major undertreated health problems, today announcedRHEA-AIneutral
